switching between glp-1 agonists ada #4 NN Clinical Use “Weighing In” on GLP-1 Receptor
Description
GLP-1RAs (Glucagon-like peptide 1 receptor agonists) benefit not only blood sugar but obese and related metabolic disorders
It has the ability to decrease blood sugar levels in a glucose-dependent manner by enhancing the secretion of insulin
GLP-1 analogs reduce hepatocyte steatosis and improve survival by enhancing the unfolded protein response and promoting macroautophagy
No appointment required
